Navigation Links
Widely used depression drug associated with dental implant failure
Date:9/3/2014

Alexandria, Va., USA The International and American Associations for Dental Research (IADR/AADR) have published a paper titled "SSRIs and the Risk of Osseointegrated Implant Failure A Cohort Study." Selective Serotonin Reuptake Inhibitors (SSRIs), the most widely used drugs for the treatment of depression, have been reported to reduce bone formation and increase the risk of bone fracture. Since osseointegration is influenced by bone metabolism, this study investigates the association between SSRIs and the risk of failures in osseointegrated implants. The manuscript, by researchers Khadijeh Al-Abedalla, Samer Abi Nader, Belinda Nicolau, Emad Rastikerdar, Faleh Tamimi and Xixi Wu, from McGill University, Montreal, Quebec, Canada; and Nach Daniel, from East Coast Oral Surgery, Moncton, New Brunswick, Canada, is published in the OnlineFirst portion of the IADR/AADR Journal of Dental Research (JDR).

This retrospective cohort study was conducted on patients treated with dental implants from January 2007 to January 2013. A total of 916 dental implants in 490 patients (94 implants on 51 patients using SSRIs) were used to estimate the risk of failure associated with the use of SSRIs. Data analysis involved cox proportional hazards, generalized estimating equations models and Kaplan-Meier analysis. After three to 67 months of follow-up, 38 dental implants failed and 784 succeeded in nonusers group while 10 failed and 84 succeeded in SSRIs-users group.

The primary outcome was that compared with non-users of SSRIs, SSRIs usage was associated with an increased risk of dental implants failure (HR= 2∙31; P< 0∙01). The failure rates were 4.6% for SSRI non-users and 10.6% SSRI users, respectively. The secondary outcomes were that small implant diameters (≤4mm) (P=0∙01), bone augmentation (P=0∙04) and smoking habits (P<0∙01) also seemed to be associated with higher risk of implant failure. The main limitation of this retrospective study was that drug compliance dose and treatment period could not be acquired from the files of the patients.

Within the limits of this study, these findings indicate that treatment with SSRIs is associated with an increased failure risk of osseointegrated implants. Please visit http://jdr.sagepub.com/content/early/recent for more information about this study or contact Ingrid L. Thomas at ithomas@iadr.org to request a PDF of the article.


'/>"/>

Contact: Ingrid L. Thomas
ithomas@iadr.org
703-299-8084
International & American Associations for Dental Research
Source:Eurekalert

Related medicine news :

1. Obstetric Complication Rates Vary Widely Between Hospitals in U.S.
2. Widely used drug no more effective than FDA approved medication in treating epileptic seizures
3. Prevalence of hepatitis C infection found to vary widely among Hispanics
4. Both real and sham acupuncture help ease side effects of widely used breast cancer drug
5. Potential for added medical benefits uncovered for widely used breast cancer drug
6. Gianluca Tognon Publishes Widely Read Blog Post Tackling 5 Lies Nutritionists Tell
7. Imprivata is the Most Widely Selected Single Sign-On Solution by U.S. Hospitals Using McKesson Paragon or Horizon According to HIMSS Analytics
8. Imprivata is the Most Widely Selected Single Sign-On Solution by U.S. Hospitals Using Siemens Soarian Clinicals according to HIMSS Analytics
9. Dehydration Widely Misunderstood, Reports Water and Health Researcher Sharon Kleyne
10. Jim Buck, Widely Considered the First Professional Dog Walker, Dies in NY at age 81
11. Rates of Serious Workplace Injuries Vary Widely by State, Allsup Reports in New Nationwide Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “The Angel”: ... the Lord has set out for each of his children. “The Angel” is the ... School of Music in New York City, and impassioned writer. , When asked of ...
(Date:1/20/2017)... ... , ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the true meaning ... of three in Oklahoma City, and a devoted woman of faith. , “Becoming a ... in the back of my mind for years, but actually doing it might have been ...
(Date:1/19/2017)... ... January 19, 2017 , ... Aerolib Healthcare ... for Clinical and Regulatory education for Physicians, Physician Advisors, Case managers, Utilization ... methodology of Disease Specific Documentation Improvement. , The Aerolib Learning Management System ...
(Date:1/19/2017)... ... January 19, 2017 , ... LabRoots , the leading ... the world, announces the launch of its newly redesigned website. The sleek new ... breakthroughs and trending news, vital information on upcoming virtual events and webinars, all ...
(Date:1/19/2017)... ... January 19, 2017 , ... Catalent ... for drugs, biologics and consumer health products, today announced that it will be ... leader in innovative excipients and drug delivery solutions to health industries worldwide. The ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , Jan. 19, 2017 ... USD 233.7 billion by 2025, according to a ... market is anticipated to be predominantly driven by ... resulting into the large-scale production of new and ... the influx of drugs at an unprecedented rate ...
(Date:1/19/2017)... -- The Global Therapy Partnering Terms and Agreements since ... and agreements entered into by the world,s leading healthcare ... deals by value - Deals listed by company A-Z, ... report provides understanding and access to the partnering deals ... companies. The report provides an analysis of partnering ...
(Date:1/19/2017)... Conference Call and Webcast to Follow Vanda Pharmaceuticals Inc. ... results for the fourth quarter of 2016 on Wednesday, February 15, ... ... PM ET on Wednesday, February 15, 2017, during which management will ... other corporate activities. To participate in the conference call, please dial ...
Breaking Medicine Technology: